Diabetes: Is the Ozempic Pill Just as Good as the Injection?
Updated on June 1, 2026
ON THIS PAGE
ON THIS PAGE
The diabetes and weight loss drug semaglutide (Ozempic) is a popular and powerful treatment option. While the injectable form of Ozempic has gotten plenty of coverage, there’s now the Ozempic pill, an oral form of the exact same drug that was previously named Rybelsus.
Is the Ozempic pill as effective as the Ozempic injection? How can you tell which form of the medication is right for you? Here’s what you need to know about oral semaglutide for type 2 diabetes.
What Is the Ozempic Pill?
The Ozempic pill is semaglutide formulated for oral administration rather than an injection. Both forms of the medication are made by the same manufacturer, Novo Nordisk, and feature the same active ingredient, semaglutide. Semaglutide, when sold under the brand name Ozempic, is intended for people with type 2 diabetes. The same drug is also sold as Wegovy in injection and pill form for the treatment of obesity.
Semaglutide is a GLP-1 receptor agonist, a drug that mimics the effect of a hormone that stimulates insulin secretion, blocks the secretion of glucagon (a hormone that raises blood sugar), and prompts feelings of fullness. Semaglutide was originally developed and approved to treat type 2 diabetes, and it remains a powerful glucose-lowering therapy. It also has a profound effect on body weight. Many semaglutide users find themselves losing weight without having to consciously cut calories.
The Ozempic pill is approved by the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes. The daily pill has been shown to result in clinically significant weight loss and blood sugar improvements, both alone and in combination with other diabetes drugs.
Next up video playing in 10 seconds
Diabetes 101: What Is Ozempic?
Are Rybelsus and Ozempic the Same Medication?
Rybelsus and the Ozempic pill are essentially the same medication.
For years, oral semaglutide was sold under the brand name Rybelsus for the treatment of diabetes. In 2026, manufacturer Novo Nordisk decided to retire the name “Rybelsus” and rename it “Ozempic” like the injectable form of the medication. This transition didn’t occur overnight, and for some time, both Rybelsus and the Ozempic pill will be available.
The two semaglutide pills have the same active pharmaceutical ingredient, so they should carry the same benefits and side effects. However, Rybelsus and the Ozempic pill aren’t quite identical: The Ozempic pill has been reformulated to increase the bioavailability of semaglutide, which allows it to be effective at lower doses than Rybelsus. As a result, the standard dosing schedule changed, so if your pharmacy switches you from Rybelsus to oral Ozempic, you may notice the dose of your medication decrease.
Is the Ozempic Pill as Effective as the Ozempic Injection?
Like the Ozempic injection, oral Ozempic can be an effective type 2 diabetes treatment, but it’s important to note that the formulations are absorbed differently by the body and therefore available in different doses.
The Ozempic pill is available in 1.5, 4, and 9 milligram (mg) daily doses, whereas Ozempic injections are available in 0.25, 0.5, 1, and 2 mg weekly doses. The Ozempic pill uses higher amounts of semaglutide than injectable Ozempic, because only a fraction of the semaglutide that enters the stomach is properly absorbed.
A study of real-world data found oral semaglutide demonstrated “similar effectiveness” to injectable semaglutide for blood sugar control. While these results suggest that the Ozempic pill and injectable Ozempic could be similarly effective for people with type 2 diabetes, the two drugs are not equivalent, practically speaking.
When tested in people with type 2 diabetes using metformin, the maximum dose of injectable Ozempic (2 mg) led to an A1C drop of 2.2 percentage points and weight loss of just over 15 pounds. The Ozempic pill is unlikely to match these results — at least not at the approved doses.
Due to the differences in the drugs’ respective dosages and how they’re absorbed by the body, medical supervision is recommended when switching from one form of Ozempic to the other.
Is the Ozempic Pill Approved for Weight Loss?
Like injectable Ozempic, the Ozempic pill is approved to treat type 2 diabetes, but in 2025, Novo Nordisk announced the FDA approval of the 25 mg Wegovy pill, the first oral GLP-1 drug approved for weight management.
In clinical trials, researchers found study participants lost an average of 16.6 percent of their total body weight while taking 25 mg of oral semaglutide. That amount of weight loss was about equal to that achieved by people using a 2.4 mg dose of injectable semaglutide, suggesting that an oral semaglutide weight loss pill could be just as effective as the injectable.
How to Take the Ozempic Pill
The Ozempic pill comes with specific administration instructions, including taking it on an empty stomach every morning, 30 minutes before eating, drinking, or using any other oral medications. You may only have up to 4 ounces (oz) of plain water during this time. If you have your breakfast too soon after taking the pill, the medication will be less effective. The pill must also be swallowed whole and never split, crushed, chewed, or dissolved.
By contrast, injectable Ozempic is administered weekly and can be taken at any time of day, with or without meals.
Side Effects of the Ozempic Pill
A substantial minority of Ozempic injection users experience gastrointestinal side effects. For some, the nausea, vomiting, or diarrhea subsides as the body acclimates to the drug, but others don’t feel better and end up stopping the drug entirely.
The Ozempic pill has similarly common side effects, especially in people starting the medication and navigating dose increases. Its FDA label also warns of some of the same rare, serious side effects as injectable Ozempic, including thyroid C-cell tumors, pancreatitis (inflammation of the pancreas), and acute kidney injury (a sudden decrease in kidney function).
Compounded Oral Semaglutide
Some online compounding pharmacies are now advertising “oral semaglutide,” but these products are not, in fact, equivalent to the Ozempic pill or Wegovy pill. These semaglutide pills are taken sublingually (dissolved under the tongue) rather than swallowed and therefore have an entirely different mechanism for absorption.
Buyers should be wary of such products, as there’s very limited research on sublingual semaglutide, and the safety and efficacy of such substances may be questionable.
The Takeaway
- Both oral and injectable forms of Ozempic use active ingredient semaglutide to mimic a hormone that stimulates insulin secretion, inhibits glucagon secretion, and induces feelings of fullness, serving as an effective treatment for type 2 diabetes.
- The daily Ozempic pill requires higher dosages than the weekly injection because only a fraction of the oral medication is absorbed by the stomach.
- While oral and injectable Ozempic offer similar blood sugar control for type 2 diabetes, medical supervision is recommended if one wants to switch forms of the drug.
- Oral Ozempic must be swallowed whole on an empty stomach every morning with no more than 4 oz of plain water, and it shares the same common gastrointestinal side effects and rare serious risks as the injection.
Resources We Trust
- Mayo Clinic: What Happens if You Take Too Much Semaglutide?
- diaTribe: Ozempic for Type 2 Diabetes: What You Need To Know
- Cleveland Clinic: Oral Diabetes Medications
- American Diabetes Association: Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
- Harvard Health Publishing: How Does Ozempic Work? Understanding GLP-1s for Diabetes, Weight Loss, and Beyond
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
- Novo Nordisk's Ozempic® Pill, the Only FDA-Approved Oral Peptide GLP-1 Medication for Adults With Type 2 diabetes, Soon to Be Available in the US. Novo Nordisk USA. May 1, 2026.
- Kommu S et al. Semaglutide. StatPearls. February 11, 2024.
- Novo Nordisk’s Rybelsus Officially Retired in US as ‘Ozempic Pill’ Takes Branding Center Stage. Fierce Pharma. May 1, 2026.
- Rybelsus and Ozempic Highlights of Prescribing Information. U.S. Food and Drug Administration. January 2026.
- Ozempic® (Semaglutide) Pill Dosing. Ozempic.
- Ozempic® (Semaglutide) Pen Dosing. Ozempic.
- Kim JC et al. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals. Pharmaceuticals. December 19, 2022.
- Klobucar S et al. Effectiveness of Oral versus Injectable Semaglutide in Adults with Type 2 Diabetes: Results from a Retrospective Observational Study in Croatia. Diabetology. February 2, 2024.
- Frías JP et al. Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg Versus 1.0 mg in Patients With Type 2 Diabetes (SUSTAIN FORTE): A Double-Blind, Randomised, Phase 3B Trial. The Lancet Diabetes and Endocrinology. September 2021.
- Novo Nordisk A/S: Wegovy® Pill Approved in the US as First Oral GLP-1 for Weight Management. Novo Nordisk USA. December 22, 2025.
- Common Side Effects. Ozempic.
- Possible Side Effects of Ozempic® (Semaglutide) Pill. Ozempic.
- IVY RX Weight Loss Review 2026: Injectable GLP-1 Program Details and How Tablet and ‘Sublingual’ Options Compare. NewsWire. January 17, 2026.
Meet Our Experts
Elise M. Brett, MD
Medical Reviewer
Elise M Brett, MD, is a board-certified adult endocrinologist. She received a bachelor's degree from the University of Michigan and her MD degree from the Icahn School of Medicine ...
Ross Wollen
Author
Ross Wollen joined Everyday Health in 2021 and now works as a senior editor, often focusing on diabetes, obesity, heart health, and metabolic health. He previously spent over a dec...